Mitochondria-dependent apoptosis induced by nanoscale hydroxyapatite in human gastric cancer SGC-7901 cells

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 1, 2007, Pages 128-132

  Chen, Xiaojuan ^a   Deng, Changsheng ^a   Tang, Shengli ^a   Zhang, Ming ^b  

^a WUHAN UNIVERSITY   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

Apoptosis; Caspase; Cytochrome c; Gastric cancer; Mitochondrial membrane potential; Nanoscale hydroxyapatite

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; DNA FRAGMENT; HYDROXYAPATITE; NANOMATERIAL; PROTEIN BAX; PROTEIN BCL 2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; DIPLOIDY; DNA CONTENT; DOSE RESPONSE; DOWN REGULATION; DRUG ANTAGONISM; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PROTEIN EXPRESSION; STOMACH CANCER;

AMINO ACID CHLOROMETHYL KETONES; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYSTEINE PROTEINASE INHIBITORS; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; DURAPATITE; ENZYME ACTIVATION; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NANOPARTICLES; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS; TIME FACTORS;

EID: 33846109965     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.128     Document Type: Article

References (28)

1. Sun X. D., Mu R., Zhou Y. S., Dai X. D., Zhang S. W., Huangfu X. M., Sun J., Li L. D., Lu F. Z., Qiao Y. L., Zhonghua Zhong Liu Za Zhi, 26, 4-9 (2004).
2. Wahl D. A., Czernuszka J. T., Eur. Cell Mater., 11, 43-56 (2006).
3. Queiroz A. C., Santos J. D., J. Mater. Sci., Mater. Med., 16, 641-646 (2005).
4. Moroni A., Pegreffi F., Cadossi M., Hoang-Kim A., Lio V., Giannini S., Expert Rev. Med. Devices, 2, 465-471 (2005).
5. Balasundaram G., Sato M., Webster T. J., Biomaterials, 27, 2798-2805 (2006).
6. Fu Q., Zhou N., Huang W., Wang D., Zhang L., Li H., J. Biomed. Mater. Res. A, 2, 156-163 (2005).
7. Liu Z. S., Tang S. L., Ai Z. L., World J. Gastroenterol, 9, 1968-1971 (2003).
8. Liu Z. S., Tang S. L., Hu J., Chin. J. Exp. Surg., 3, 266-268 (2006).
9. Chen C., Wang L. M., Prac. J. Oncol., 6, 459-461 (2003).
10. Hengartner, M. O., Nature (London), 407, 770-776 (2000).
11. Chang H. K., Shin M. S., Yang H. Y., Lee J. W., Kim Y. S., Lee M. H., Kim J., Kim K. H., Kim C. J., Biol. Pharm. Bull., 29, 1597-1602 (2006).
12. Dong H. L., Taesun P., Kim H. W., Biol. Pharm. Bull., 29, 648-654 (2006).
13. Ujibe M., Kanno S., Osanai Y., Koiwai K., Ohtake T., Kimura K., Uwai K., Takeshita M., Ishikawa M., Biol. Pharm. Bull., 28, 2338-2341 (2005).
14. Zimmermann K. C., Bonzon C., Green D. R., Pharmacol. Ther., 92, 57-70 (2001).
15. Bodmer J. L., Schneider P., Tschopp J., Trends Biochem. Sci., 27, 19-26 (2002).
16. Bratton S. B., Cohen G. M., Trends Pharmacol. Sci., 22, 306-315 (2001).
17. Creagh E. M., Martin S. J., Biochem. Soc. Trans., 29, 696-701 (2001).
18. Huang J., Wu L. J., Tashiro S., Onodera S., Ikejima T., Biol. Pharm. Bull., 28, 2068-2074 (2005).
19. Cho S. G., Choi E. J., J. Biochem. Mol. Biol., 1, 24-27 (2002).
20. Ho P. K., Hawkins C. J., FEBS J., 272, 5436-5453 (2005).
21. Zimmermann K. C., Green D. R., J. Allergy Clin. Immunol., 108, s99-s103 (2001).
22. Hajra K. M., Liu J. R., Apoptosis, 9, 691-704 (2004).
23. Compton M. M., Cancer Metastasis Rev., 11, 105-109 (1992).
24. Schafer Z. T., Kornbluth S., Dev. Cell., 5, 549-561 (2006).
25. Mohamad N., Gutierrez A., Nunez M., Cocca C., Martin G., Cricco G., Medina V., Rivera E., Bergoc R., Biocell, 29, 149-161 (2005).
26. Martinou J. C., Green D. R., Nat. Rev. Mol. Cell Biol., 2, 63-67 (2001).
27. Cory S., Adams J. M., Nat. Rev. Cancer, 2, 647-656 (2002).
28. Green D. R., Reed J. C., Science, 281, 1309-1312 (1998).